Number of shares outstanding for Gilead Sciences (GILD)

Number of shares outstanding as of September 2024 : 1,247,000,000

According to Gilead Sciences's latest financial reports and stock price the company's current number of shares outstanding is 1,247,000,000. At the end of 2024 the company had 1,247,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Gilead Sciences from 2013 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	1.24 B	-0.08%
2023	1.24 B	-0.32%
2022	1.25 B	-0.32%
2021	1.25 B	0.08%
2020	1.25 B	-0.87%
2019	1.26 B	-1.86%
2018	1.29 B	-1.3%
2017	1.30 B	-0.68%
2016	1.31 B	-8.36%
2015	1.43 B	-4.65%
2014	1.50 B	-1.82%
2013	1.53 B

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Amgen AMGN	537,000,000	-56.94%	🇺🇸 USA
Vertex Pharmaceuticals VRTX	258,100,000	-79.30%	🇺🇸 USA
AbbVie ABBV	1,768,000,000	41.78%	🇺🇸 USA
Illumina ILMN	159,000,000	-87.25%	🇺🇸 USA
Biogen BIIB	145,600,000	-88.32%	🇺🇸 USA
Pfizer PFE	5,666,000,000	354.37%	🇺🇸 USA
Johnson & Johnson JNJ	2,406,800,000	93.01%	🇺🇸 USA
Eli Lilly LLY	900,900,000	-27.75%	🇺🇸 USA
Merck MRK	2,535,649,470	103.34%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions